The nitrogen donor that coordinates copper in GHK-Cu
Yoh K, Itoh K, Enomoto A, Hirayama A, Yamaguchi N, Kobayashi M, et al
[1] [2] These findings have generated considerable scientific interest, though it is important to note that Phase 2 data involve smaller sample sizes and shorter durations than the Phase 3 trials required for regulatory approval
Important Notice This product is intended exclusively for laboratory and scientific research purposes
For many patients, these symptoms diminish over time as the body adapts to the medication, as noted in the Summaries of Product Characteristics (SmPCs)
Non-oral forms of contraception that bypass the digestive system are not believed to be affected by GLP-1 medications